An appointment can create more than one ROC filing even when it is one management decision. The clearest example is a managing director or whole-time director. The appointment can trigger MR-1 because Section 196 and Rule 3 deal specifically with managerial personnel, while DIR-12 separately updates the Registrar’s record of directors and key managerial personnel.
The two forms therefore should not be treated as alternatives. The current MCA MR-1 instruction kit says MR-1 is used for appointment of a manager, managing director or whole-time director and is filed within 60 days of appointment. The current MCA DIR-12 instruction kit says DIR-12 reports appointments, cessations and designation changes of directors and key managerial personnel and is generally filed within 30 days of the event.
MR-1 answers a narrower question than DIR-12
MR-1 is tied to the appointment of three managerial positions: manager, managing director and whole-time director. Rule 3 of the Companies (Appointment and Remuneration of Managerial Personnel) Rules requires a company to file the return within 60 days of the appointment. Section 196 of the Companies Act contains the related appointment framework and also states that the prescribed return is to be filed within 60 days.
That scope matters because older checklists sometimes describe MR-1 as a general return for every key managerial personnel appointment. The rule was amended in 2016 to remove the references to Chief Executive Officer, Company Secretary and Chief Financial Officer. The current MR-1 webform also presents manager, managing director and whole-time director as the relevant designations.
So the practical test is not simply, “Is this person a KMP?” It is, “Is this appointment one of the three positions for which Rule 3 prescribes MR-1?”
DIR-12 keeps the Registrar’s director and KMP record current
DIR-12 has a broader record-updating function. Section 170(2) of the Companies Act, 2013 on India Code requires a return of prescribed particulars of directors and key managerial personnel within 30 days of appointment and within 30 days of a change. The MCA DIR-12 instruction kit applies that rule to appointment, cessation and change in designation.
A managing director and whole-time director sit inside both worlds: they are directors/KMP for the DIR-12 record and they are managerial personnel for MR-1. A manager may not be a director, but “manager” is still within the statutory KMP framework, so the DIR-12 analysis does not disappear merely because there is no directorship.
By contrast, a person appointed only as CFO, Company Secretary or CEO does not fall within the present Rule 3 MR-1 list merely because the person is KMP. DIR-12 remains the relevant appointment/change filing under the director-and-KMP reporting framework, subject to the facts of the appointment.
When both forms arise from the same appointment
Assume an existing director is appointed as managing director with effect from 1 October. There are two distinct filing questions:
- DIR-12: the company has a change in the person’s designation and KMP/director particulars. The current DIR-12 framework uses a 30-day filing period.
- MR-1: the person has been appointed as managing director, which is one of the positions expressly covered by Rule 3. MR-1 has a 60-day statutory period.
Filing DIR-12 does not satisfy the MR-1 requirement, and filing MR-1 does not update the DIR-12 record in place of DIR-12. A compliance calendar should create both tasks where both triggers exist.
The same logic applies when a company appoints a whole-time director. For a manager who is not a director, MR-1 still applies because “manager” is expressly named in Rule 3, while DIR-12 should be tested and filed under the KMP reporting framework.
The shorter deadline should drive the internal timetable
Where an appointment requires both filings, waiting for the 60-day MR-1 date can make DIR-12 late. The safer control is to build the file around the earlier 30-day DIR-12 deadline and then close MR-1 within its separate 60-day period.
The Board resolution date and the effective appointment date should also be recorded separately. The MR-1 webform asks for both the Board resolution date and the effective date of appointment. The DIR-12 process is likewise event-based. If the appointment is effective on a different date from the meeting date, the company should not casually copy one date into every filing without checking the governing event and the live form instructions.
A well-kept appointment file should therefore contain the approved terms, effective date, Board and member approvals where applicable, the correct designation, the DIN/PAN or other identifier required by the form, and evidence that each resulting filing was completed against its own clock.
MR-1 is not the whole Section 196 approval process
MR-1 reports the appointment; it does not by itself prove that the appointment and remuneration were validly approved. Section 196 contains separate conditions around appointment of a managing director, whole-time director or manager, including a maximum term of five years at a time and age/disqualification conditions. It also links the appointment and remuneration process to Section 197 and Schedule V.
The current MR-1 instruction kit reflects that wider framework. It asks for appointment and remuneration information and contains fields for a related MGT-14 SRN where applicable and an MR-2 SRN where Central Government approval is applicable. Those fields are a reminder that the filing sequence depends on the legal facts; MR-1 should not be treated as a substitute for the approvals that came before it.
The underlying Board meeting record should match the designation, tenure, remuneration and effective date later reported in the forms. A mismatch between the Board approval, appointment letter and ROC filing is more difficult to explain than a filing prepared from one controlled appointment sheet.
MGT-14 is a separate question, especially for a managing director
Section 117 has its own filing triggers. In particular, a Board resolution or agreement relating to the appointment, re-appointment, renewal or variation of terms of appointment of a managing director is one of the matters that should be tested under the MGT-14 framework. That filing is separate from both DIR-12 and MR-1.
This does not mean every managerial-personnel event should automatically be given the same MGT-14 treatment. The better approach is to map the exact resolution and company-specific position against Section 117 and the MGT-14 filing triggers. The appointment file can then show why MGT-14 was filed, or why it was not required for that particular resolution.
Three examples that prevent the most common form mix-up
Existing director becomes managing director
Hypothetical example: A director is re-designated and appointed as managing director. The company should ordinarily create a DIR-12 task for the designation/KMP change and an MR-1 task for the managerial appointment. It should separately test the managing-director resolution under Section 117/MGT-14 and check the Section 196, Section 197 and Schedule V approval conditions.
A CFO is appointed
Hypothetical example: A company appoints a new CFO but does not appoint that person as manager, managing director or whole-time director. The CFO is within the KMP reporting framework for DIR-12, but the current Rule 3 scope does not require MR-1 merely because the appointee is a CFO.
A manager is appointed who is not a director
Hypothetical example: A company appoints an individual as “manager” within the Companies Act framework, but the person does not join the Board. MR-1 still applies because Rule 3 expressly names a manager. DIR-12 must also be handled under the KMP reporting framework. The absence of a directorship does not turn MR-1 into the only filing.
A practical appointment-to-filing control
- Identify the exact legal office. Do not use “KMP” as the only label. Record whether the person is MD, WTD, manager, CEO, CFO, CS or holds more than one recognised capacity.
- Fix the effective date and tenure. Keep the Board resolution date separate from the effective appointment date where they differ.
- Complete the appointment approvals. Apply Section 196, Section 197, Schedule V, the articles and any other company-specific approval requirement before treating the ROC forms as the main compliance.
- Create the DIR-12 task. For a reportable director/KMP appointment, cessation or designation change, work to the current 30-day DIR-12 timeline.
- Create the MR-1 task where Rule 3 applies. If the office is manager, managing director or whole-time director, complete the separate MR-1 return within the 60-day statutory period.
- Test MGT-14 and MR-2 separately. Do not infer their applicability only from the fact that MR-1 is required.
- Reconcile the forms before submission. Name, DIN/PAN, designation, Board resolution, effective date, tenure and remuneration should tell the same story across the supporting documents and filings.
- Close the post-appointment records. Update the statutory register and, where the appointee is a director, complete the relevant interest-disclosure process. The separate Section 184 and MBP-1 workflow explains that director-level step.
The simplest way to remember the distinction is that DIR-12 updates who holds the director/KMP office and what changed, while MR-1 is the additional return for appointment of an MD, WTD or manager. When one appointment fits both descriptions, both filing tracks need attention. Building the compliance calendar around the shorter DIR-12 period, and then completing MR-1 and any separate resolution/approval filings, avoids the common mistake of treating one ROC form as a substitute for another.
